Company intelligence / Profile preview

Aescuven Pharma Deutschland

Baden-Baden, Baden-Württemberg, Germany
Ownership
Private
Employees
~120
Development stage
Other
01

Overview

Cesra Arzneimittel is a German pharmaceutical company specializing in the development and manufacture of phytopharmaceuticals and high-quality skincare products. Based in Baden-Baden and founded in 1929, the company is widely recognized for its flagship product, Aescuven, which utilizes horse chestnut seed extract to treat chronic venous insufficiency. Beyond vascular health, Cesra is a leader in herbal dermatology, notably through its Ilon brand of ointments for skin inflammation and abscesses. The company operates as part of the Redel Foundation, dedicating a significant portion of its profits to humanitarian aid and global health projects. Cesra maintains a strong focus on natural ingredients backed by scientific research, distributing its portfolio to pharmacies and healthcare providers worldwide.

Therapeutic areas
CardiovascularDermatologyInfectious Diseases
Modalities
Small moleculePlant extract
Industry
Biotech

Beyond the preview

Go deeper on Aescuven Pharma Deutschland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aescuven Pharma Deutschland.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call